Narcotic Free TIVA and Incidence of Unacceptable Movements Under Anesthesia During ACDF Surgery

• Status: Recruiting
• Trial end date: 2022-12-01
• Target enrollment: 0
• Participant gender: All

Summary

This study will help the investigators learn more about the best way to give anesthesia for these kinds of surgery. The investigators will be using 2 different groups of medications that is commonly used in ACDF surgery, one group has a Narcotic, and the other group does not. The investigators wish to test whether a narcotic free anesthetic will result in an overall safer surgery, better patient recovery, and satisfaction. The investigators think also that eliminating the Narcotic from the Anesthetic regimen will allow patients to recover faster after surgery , and consume less pain medicines in the postoperative period.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Arkansas
• Treatments: Anesthetics; Dexmedetomidine; Ketamine; Narcotics; Remifentanil

Criteria

Inclusion Criteria

• Men and women 18- to 80-years old

• ASA 1, 2, 3

• 1 or 2 levels ACDF

Exclusion Criteria

• ASA 4

• Seizure disorders

• Chronic narcotic use

• Opiate abuse

• Major cardiac comorbidity, or significantly elevated blood pressure

• Known hypersensitivity to fentanyl analogs, ketamine, or propofol injectable emulsions.

• Known allergy to eggs, egg products, soybeans, or soy products